Axltide

Axltide is a synthetic peptide substrate specifically designed for the study of tyrosine kinase activity, particularly in relation to the AXL receptor tyrosine kinase. As a short, defined peptide sequence, Axltide provides a valuable tool for dissecting phosphorylation events and signal transduction pathways in cellular and biochemical research. Its structure makes it an ideal substrate for in vitro kinase assays, facilitating the investigation of enzyme kinetics, substrate specificity, and the modulation of kinase-driven signaling cascades. The utility of Axltide extends across a range of research contexts, from fundamental studies of receptor signaling mechanisms to the development of kinase inhibitors and the characterization of intracellular communication networks.

Kinase activity assays: Axltide is widely employed as a substrate in kinase activity assays, enabling precise measurement of AXL and related tyrosine kinase function. By incorporating this peptide into in vitro phosphorylation reactions, researchers can quantitatively assess kinase catalytic efficiency, substrate affinity, and the impact of experimental variables such as co-factors or inhibitors. The defined sequence of Axltide provides high specificity, reducing background phosphorylation and enhancing the reliability of assay readouts in both endpoint and continuous monitoring formats.

Signal transduction research: The peptide's selective recognition by AXL and similar kinases makes it an important tool for probing downstream signaling events in cellular models. By tracking the phosphorylation state of Axltide, scientists can elucidate the dynamics of receptor activation, map signaling pathways, and identify regulatory nodes within complex biochemical networks. This application is particularly valuable in studies aiming to understand the role of AXL-mediated signaling in processes such as cell proliferation, migration, and survival.

Inhibitor screening and drug discovery: Axltide serves as a robust platform for high-throughput screening of small molecule kinase inhibitors. Its use as a standardized substrate allows for reproducible evaluation of compound potency and selectivity against AXL and related tyrosine kinases. This approach accelerates the identification and optimization of lead molecules in early-stage drug discovery, supporting the development of targeted modulators for research applications.

Enzyme kinetics and mechanism studies: The defined nature of Axltide enables detailed kinetic analyses of tyrosine kinase catalysis. Researchers can utilize the peptide to determine key parameters such as Km and Vmax, investigate the effects of point mutations within the kinase domain, and explore the mechanistic basis of substrate recognition and phosphorylation. Such studies provide fundamental insights into enzyme function and contribute to the broader understanding of protein phosphorylation in cellular regulation.

Analytical method development: Axltide's consistent and well-characterized sequence makes it a preferred choice for developing and validating analytical techniques, including mass spectrometry-based phosphorylation detection and immunoassay platforms. Its use as a calibration standard or control substrate ensures accuracy and reproducibility in quantitative assays, supporting rigorous assessment of kinase activity across diverse experimental systems. By facilitating the standardization of analytical workflows, the peptide enhances the reliability of biochemical data and supports comparative studies in kinase research.

1. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. High fat diet and GLP-1 drugs induce pancreatic injury in mice

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. The spatiotemporal control of signalling and trafficking of the GLP-1R